 |
PDBsum entry 1ksw
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
Bound ligand (Het Group name = )
matches with 79.41% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Chem Biol
9:25-33
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phospho-acceptor specificity of the wild-type enzyme.
|
|
L.A.Witucki,
X.Huang,
K.Shah,
Y.Liu,
S.Kyin,
M.J.Eck,
K.M.Shokat.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The direct substrates of one protein kinase in a cell can be identified by
mutation of the ATP binding pocket to allow an unnatural ATP analog to be
accepted exclusively by the engineered kinase. Here, we present structural and
functional assessment of peptide specificity of mutant protein kinases with
unnatural ATP analogs. The crystal structure (2.8 A resolution) of c-Src (T338G)
with N(6)-(benzyl) ADP bound shows that the creation of a unique nucleotide
binding pocket does not alter the phospho-acceptor binding site of the kinase. A
panel of optimal peptide substrates of defined sequence, as well as a degenerate
peptide library, was utilized to assess the phospho-acceptor specificity of the
engineered "traceable" kinases. The specificity profiles for the
mutant kinases were found to be identical to those of their wild-type
counterparts.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Chemical Structures of A*TP Analogs Used in This
Study1: N^6-(benzyl) ATP; 2: N^6-(cyclopentyl) ATP. Definitions
of analog-sensitive (as) kinase mutants used in this study.
|
 |
Figure 2.
Figure 2. Comparison of Wild-Type and Analog-Specific c-Src
Crystal Structures(A) The crystal structure of c-Src-as1
superimposed on wild-type c-Src. c-Src-as1 is shown in gray, and
c-Src is in red. The rmsd for the overlay is 0.35 Å.(B)
The binding of the A*TP analog, N^6-(benzyl) ADP to the mutant
c-Src (T338G) kinase. The surface corresponding to the glycine
residue at the 338 position is colored red. The benzyl ring of
the A*TP analog projects into a pocket in the nucleotide binding
cleft. This pocket is made accessible by the c-Src (T338G) point
mutation. For clarity, the 11 residues that bind over the
nucleotide at the front of the nucleotide cleft are omitted from
the figure in order to more clearly show the surface at the back
of the nucleotide binding pocket where the 338 residue lies. The
omitted residues are c-Src 272–282.(C) The steric clash of the
wild-type c-Src threonine residue at the 338 position, shown in
red, with the N^6-(benzyl) ATP analog (blue). The gray surface
was built over the crystal structure of the mutant kinase
overlayed with the wild-type c-Src crystal structure, and the
surface was rendered over threonine 338 (red). The N^6-(benzyl)
ADP (blue) is superimposed on the AMP-PNP ligand (yellow).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Chem Biol
(2002,
9,
25-33)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.Su,
D.M.Bryant,
F.Luton,
M.Vergés,
S.M.Ulrich,
K.C.Hansen,
A.Datta,
D.J.Eastburn,
A.L.Burlingame,
K.M.Shokat,
and
K.E.Mostov
(2010).
A kinase cascade leading to Rab11-FIP5 controls transcytosis of the polymeric immunoglobulin receptor.
|
| |
Nat Cell Biol,
12,
1143-1153.
|
 |
|
|
|
|
 |
L.M.Elphick,
S.E.Lee,
E.S.Child,
A.Prasad,
C.Pignocchi,
S.Thibaudeau,
A.A.Anderson,
L.Bonnac,
V.Gouverneur,
and
D.J.Mann
(2009).
A quantitative comparison of wild-type and gatekeeper mutant cdk2 for chemical genetic studies with ATP analogues.
|
| |
Chembiochem,
10,
1519-1526.
|
 |
|
|
|
|
 |
T.P.Abeyweera,
X.Chen,
and
S.A.Rotenberg
(2009).
Phosphorylation of alpha6-tubulin by protein kinase Calpha activates motility of human breast cells.
|
| |
J Biol Chem,
284,
17648-17656.
|
 |
|
|
|
|
 |
B.E.Turk
(2008).
Understanding and exploiting substrate recognition by protein kinases.
|
| |
Curr Opin Chem Biol,
12,
4.
|
 |
|
|
|
|
 |
Y.Mori,
T.Hirokawa,
K.Aoki,
H.Satomi,
S.Takeda,
M.Aburada,
and
K.Miyamoto
(2008).
Structure activity relationships of quinoxalin-2-one derivatives as platelet-derived growth factor-beta receptor (PDGFbeta R) inhibitors, derived from molecular modeling.
|
| |
Chem Pharm Bull (Tokyo),
56,
682-687.
|
 |
|
|
|
|
 |
J.A.Blair,
D.Rauh,
C.Kung,
C.H.Yun,
Q.W.Fan,
H.Rode,
C.Zhang,
M.J.Eck,
W.A.Weiss,
and
K.M.Shokat
(2007).
Structure-guided development of affinity probes for tyrosine kinases using chemical genetics.
|
| |
Nat Chem Biol,
3,
229-238.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.J.Allen,
M.Li,
C.S.Brinkworth,
J.L.Paulson,
D.Wang,
A.Hübner,
W.H.Chou,
R.J.Davis,
A.L.Burlingame,
R.O.Messing,
C.D.Katayama,
S.M.Hedrick,
and
K.M.Shokat
(2007).
A semisynthetic epitope for kinase substrates.
|
| |
Nat Methods,
4,
511-516.
|
 |
|
|
|
|
 |
K.Shah,
and
F.Vincent
(2005).
Divergent roles of c-Src in controlling platelet-derived growth factor-dependent signaling in fibroblasts.
|
| |
Mol Biol Cell,
16,
5418-5432.
|
 |
|
|
|
|
 |
J.A.Whitney
(2004).
Reference systems for kinase drug discovery: chemical genetic approaches to cell-based assays.
|
| |
Assay Drug Dev Technol,
2,
417-429.
|
 |
|
|
|
|
 |
L.Wan,
T.de los Santos,
C.Zhang,
K.Shokat,
and
N.M.Hollingsworth
(2004).
Mek1 kinase activity functions downstream of RED1 in the regulation of meiotic double strand break repair in budding yeast.
|
| |
Mol Biol Cell,
15,
11-23.
|
 |
|
|
|
|
 |
Y.Liu,
C.Kung,
J.Fishburn,
A.Z.Ansari,
K.M.Shokat,
and
S.Hahn
(2004).
Two cyclin-dependent kinases promote RNA polymerase II transcription and formation of the scaffold complex.
|
| |
Mol Cell Biol,
24,
1721-1735.
|
 |
|
|
|
|
 |
J.A.Ubersax,
E.L.Woodbury,
P.N.Quang,
M.Paraz,
J.D.Blethrow,
K.Shah,
K.M.Shokat,
and
D.O.Morgan
(2003).
Targets of the cyclin-dependent kinase Cdk1.
|
| |
Nature,
425,
859-864.
|
 |
|
|
|
|
 |
P.M.Fischer
(2003).
CDK versus GSK-3 inhibition: a purple haze no longer?
|
| |
Chem Biol,
10,
1144-1146.
|
 |
|
|
|
|
 |
K.Shokat,
and
M.Velleca
(2002).
Novel chemical genetic approaches to the discovery of signal transduction inhibitors.
|
| |
Drug Discov Today,
7,
872-879.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |